Notably, in chronic inflammation, such as Alzheimer’s disease, both 5-HT2b and BDNF levels are elevated, paradoxically contributing to neurotoxicity as BDNF released near amyloid plaques promotes TNF-α and glutamate release [35,36,37]. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.